LAB.00036 Multiplex Autoantigen Microarray Testing for Systemic Lupus Erythematosus

This policy addresses multiplex autoantigen microarray testing (multiplex autoantibody microarray panels) for screening, diagnosis, or management of systemic lupus erythematosus (SLE). Anthem deems this testing investigational/experimental and not medically necessary; therefore, it is not covered. Noncoverage applies to all indications and care settings (screening, initial diagnosis, monitoring/management), with no eligible circumstances for coverage.

"Multiplex autoantigen microarray testing to screen for, diagnose, or manage systemic lupus erythematous is consideredinvestigational and not medically necessary."

Sign up to see full coverage criteria, indications, and limitations.